rabeprazole has been researched along with Disease Exacerbation in 6 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two hundred and forty-three patients received rabeprazole (20 mg or 10 mg) or omeprazole (20 mg) once daily for up to 5 years, for gastro-oesophageal reflux disease and 51% completed the whole 5 year period." | 5.11 | Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa. ( Fiocca, R; Jacobs, A; Miller, N; Morocutti, A; Rindi, G; Thjodleifsson, B, 2005) |
| "The incidence of esophageal cancer continues to rise in the Western world." | 2.49 | Impact of inflammation-metaplasia-adenocarcinoma sequence and prevention in surgical rat models. ( Fujimura, T; Fushida, S; Harmon, JW; Hattori, T; Miwa, K; Miyashita, T; Ninomiya, I; Nishijima, K; Ohta, T; Oyama, K; Sasaki, S; Shah, FA, 2013) |
| "Patients with GERD and a control group of healthy asymptomatic volunteers were recruited." | 1.37 | Non-erosive reflux disease (NERD), symptomatic and asymptomatic erosive reflux disease (ERD): from hypersensitive to hyposensitive esophagus. ( Goh, KL; Hartono, JL; Qua, CS, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okamoto, T | 1 |
| Hatakeyama, S | 1 |
| Hosogoe, S | 1 |
| Tanaka, Y | 1 |
| Imanishi, K | 1 |
| Takashima, T | 1 |
| Saitoh, F | 1 |
| Suzuki, T | 1 |
| Ohyama, C | 1 |
| Hartono, JL | 1 |
| Qua, CS | 1 |
| Goh, KL | 1 |
| Fujiwara, S | 1 |
| Morita, Y | 1 |
| Toyonaga, T | 1 |
| Kawakami, F | 1 |
| Itoh, T | 1 |
| Yoshida, M | 1 |
| Kutsumi, H | 1 |
| Azuma, T | 1 |
| Miyashita, T | 2 |
| Shah, FA | 2 |
| Harmon, JW | 2 |
| Marti, GP | 1 |
| Matsui, D | 1 |
| Okamoto, K | 1 |
| Makino, I | 1 |
| Hayashi, H | 1 |
| Oyama, K | 2 |
| Nakagawara, H | 1 |
| Tajima, H | 1 |
| Fujita, H | 1 |
| Takamura, H | 1 |
| Murakami, M | 1 |
| Ninomiya, I | 2 |
| Kitagawa, H | 1 |
| Fushida, S | 2 |
| Fujimura, T | 2 |
| Ohta, T | 2 |
| Miwa, K | 1 |
| Sasaki, S | 1 |
| Nishijima, K | 1 |
| Hattori, T | 1 |
| Rindi, G | 1 |
| Fiocca, R | 1 |
| Morocutti, A | 1 |
| Jacobs, A | 1 |
| Miller, N | 1 |
| Thjodleifsson, B | 1 |
2 reviews available for rabeprazole and Disease Exacerbation
| Article | Year |
|---|---|
Do proton pump inhibitors protect against cancer progression in GERD?
Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Barrett Esop | 2013 |
Impact of inflammation-metaplasia-adenocarcinoma sequence and prevention in surgical rat models.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Animals; Disease Models, Animal; Disease Pr | 2013 |
2 trials available for rabeprazole and Disease Exacerbation
| Article | Year |
|---|---|
A randomized controlled trial of rebamipide plus rabeprazole for the healing of artificial ulcers after endoscopic submucosal dissection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Alanine; Anti-Ulcer Agents; Disease Progression; Drug | 2011 |
Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Dis | 2005 |
2 other studies available for rabeprazole and Disease Exacerbation
| Article | Year |
|---|---|
Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis.
Topics: Aged; Aorta, Abdominal; Computed Tomography Angiography; Disease Progression; Esomeprazole; Female; | 2018 |
Non-erosive reflux disease (NERD), symptomatic and asymptomatic erosive reflux disease (ERD): from hypersensitive to hyposensitive esophagus.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Case-Control Studies; Disease Progression; Fem | 2011 |